PDCD1 and vitiligo: The mechanism behind PD-1 inhibitor associated vitiligo is likely due to aberrant recognition of antigens in the dermis and epidermis by reactivated CD4+/CD8+ T cells, thereby leading to a potent inflammatory process (55).